EconomyEli Lilly raises revenue outlook as weight-loss injections offset Foundayo shortfall
Eli Lilly lifted its full-year revenue forecast and topped third-quarter profit estimates on Thursday. Strong demand for its injectable weight-loss drugs offset a weaker-than-expected launch of its obesity pill, Foundayo, and shares jumped.
R
Reuters★★★☆☆2026-10-29 14:40Original
Eli Lilly raises revenue outlook as weight-loss injections offset Foundayo shortfall
Economy